Safety and Pharmacokinetics of Islatravir in Individuals with Severe Renal Insufficiency

Matthews, RP; Cao, YF; Patel, M; Weissler, VL; Bhattacharyya, A; De Lepeleire, I; Last, S; Rondon, JC; Vargo, R; Stoch, SA; Iwamoto, M

Matthews, RP (通讯作者)，Merck & Co Inc, Rahway, NJ 07065 USA.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022; 66 (12):

Abstract

Islatravir (MK-8591) is a high-potency reverse transcriptase translocation inhibitor in development for the treatment of HIV-1 infection. Data from pr......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索